Priority Date: 15.03.11 (US 201161452976P)

Overcoming resistance to ERBB pathway inhibitors

  • Application ID: EP14166702
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1113.55
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) J A Kemp is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 185 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.03.2011 - Priority Date (US 201161452976P)
  • 24.12.2014 - Publication A1 (EP2815765)